Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours
- 19 May 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 139 (2) , 199-205
- https://doi.org/10.1016/s0304-3835(99)00045-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling PathwayJournal of Biological Chemistry, 1997
- AH RECEPTOR SIGNALING PATHWAYSAnnual Review of Cell and Developmental Biology, 1996
- The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.British Journal of Clinical Pharmacology, 1995
- The Aryl Hydrocarbon Receptor ComplexAnnual Review of Pharmacology and Toxicology, 1995
- Role of Human Cytochromes P450 in the Metabolic Activation of Chemical Carcinogens and ToxinsDrug Metabolism Reviews, 1994
- Expression of CYP1A1 and CYP1A2 genes in human liverPharmacogenetics, 1993
- Induction of Cytochrome P4501 as an Indicator of Potential Chemical CarcinogenesisDrug Metabolism Reviews, 1993
- Regulation of CYP1A1 expressionThe FASEB Journal, 1992
- Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridizationHepatology, 1991
- Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymesChemical Research in Toxicology, 1991